First results of the GAIN/iCAT2 Consortium trial show the importance of molecular profiling for the diagnosis and treatment of solid tumours in young patients.
In patients with severe COVID-19 pneumonia and hyper-inflammation, mavrilimumab was associated with decreased mechanical ventilation and death compared with placebo.
PET/CT showed a discriminating value in measuring disease activity in large-vessel vasculitis (LVV). This finding was consistent in giant cell arteritis (GCA) and Takayasu’s arteritis (TAK) subgroups.
In patients with VERA on methotrexate + tocilizumab combination therapy, ultrasound imaging was able to detect treatment response in an earlier stage than clinical examination scores.
During the COVID-19 pandemic, rheumatoid arthritis remote management is a feasible alternative for routine outpatient follow-up according to a prospective, longitudinal real-world study of UK patients.
Breast cancer has a greater impact on the quality of life and work of those affected than previously assumed,as found by an ongoing study focused on women with breast cancer during therapy.
MDA following a treat-to-target strategy in early PsA can be predicted by a combination of factors, including Tender Joint Count, PGA of disease activity, pain, and the absence of enthesitis and dactylitis.
Exposure to passive smoking in childhood and/or adulthood is associated with RA increased risk, according to the large prospective E3N-EPIC cohort study of French women.
In a recent study, a significant improvement in PFS probability was observed in the treatment of patients with advanced castration-resistant prostate cancer through the use of ribociclib, docetaxel and prednisone.
Fecal microbiota transplantation (FMT) as an add-on therapy to methotrexate was inferior to treat active PsA, compared to sham in a proof-of-concept, randomized, placebo-controlled FLORA trial.
Researchers are developing a new generation of microimplants which can be charged completely wirelessly using ultrasound waves.
Patients with cancer who are infected with the coronavirus have an increased risk of severe COVID-19 disease.
According to a case-crossover study, a poor response to bDMARDs in CIA patients is associated with air pollution; adding to further evidence to its relevance as a factor in rheumatic diseases.
esanum, as SHC 2021 digital media partner, chats with Conference President Prof. Seng Gee Lim about the virtual international conference on the prevention and treatment of liver diseases.
In 2021, the EULAR Congress will focus on People with Arthritis and Rheumatism in Europe (PARE) and Health Professionals in Rheumatology (HPR). A total of over 2,700 abstracts were submitted.
Scientists at the Institute of Science and Technology (IST) Austria have studied a high-risk gene and discovered its important role during a critical phase of brain development.
Fifty of these died in a single day on Sunday 18 May. In India, the second wave has been ongoing since early April.
A collaboration between researchers from Yale University and Papa Giovanni XXIII Hospital, Italy has made it possible to analyse and reproduce the pathological mechanism by which COVID-19 causes liver damage.
From 31 May to 4 June 2021, esanum will stream the SHC, a global meeting on the prevention and treatment of liver diseases. Physicians can register for esanum’s livestream of the five-day webinar program.
Advice from coaches for physicians who want to change careers or reorient themselves.